Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/30/2012CN101564438B Application of Chinese medicinal composition in preparation of medicament for treating acute severe brain injury
05/30/2012CN101564405B Application of total aglycone of himalayan teasel roots and single-component hederagenin in medicaments preparing Alpha-glucosidase inhibitor
05/30/2012CN101563321B 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
05/30/2012CN101563320B [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
05/30/2012CN101559218B Composition with function of increasing bone density
05/30/2012CN101550119B Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same
05/30/2012CN101544638B Lact-pyrondridin and its pharmaceutical composition
05/30/2012CN101537170B Compound for preventing osteoporosis and osteoarthrosis
05/30/2012CN101534835B L-OddC prodrugs for cancer
05/30/2012CN101524465B External dipping medicine for remedying cancer
05/30/2012CN101522906B Purification of streptococcus pneumoniae type 3 polysaccharides
05/30/2012CN101516366B Oxindole derivatives as anticancer agents
05/30/2012CN101511799B Cyclic amine compound
05/30/2012CN101506204B Human protein tyrosine phosphatase inhibitors and methods of use
05/30/2012CN101505777B Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia
05/30/2012CN101502530B Medicament composition containing ginseng saponin and periplocin and uses thereof
05/30/2012CN101502516B Glipizide enteric-coated formulation composition and method for preparing the same
05/30/2012CN101492711B Uses of MAGEA9 gene
05/30/2012CN101491676B Ibuprofen compositions
05/30/2012CN101490076B 3'-ethynylcytidine derivative
05/30/2012CN101479254B C-phenyl 1-thioglucitol compound
05/30/2012CN101475594B Liver targeted antivirus precursor medicament annular phosphoester and use thereof
05/30/2012CN101474319B Nasal spray microemulsion preparation for clearing brain, preparation method and application thereof
05/30/2012CN101472922B Novel benzo buprofezin derivate and application thereof as antibacterial agent
05/30/2012CN101460468B 2-pyrazinecarboxamide derivatives
05/30/2012CN101455643B Dry suspension and preparation method thereof
05/30/2012CN101455628B Preparation method of gel composition for eyes
05/30/2012CN101450912B Tetrahydronaphthalene substituted benzoic acid derivates
05/30/2012CN101450137B Preparation method of anti-virus traditional Chinese medicine
05/30/2012CN101445492B Amide thiazole derivant, preparation method and use thereof
05/30/2012CN101443022B Use of a growth-stimulating protein
05/30/2012CN101437805B Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
05/30/2012CN101429200B Tricyclic benzopyran compound as anti-arrhythmic agents
05/30/2012CN101421243B Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
05/30/2012CN101420951B Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
05/30/2012CN101415678B Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists
05/30/2012CN101411693B Oral dosage form for controlled drug release
05/30/2012CN101402667B Glycosylation modified nitric oxide donor type oleaolic acid compounds, preparation and uses thereof
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/30/2012CN101385794B Guizhen medicine for treating burn
05/30/2012CN101378657B Nucleic acid-degrading agent and method for degradation of nucleic acid
05/30/2012CN101375928B Pharmaceutical combination for preventing birth-defect and improving memory
05/30/2012CN101375926B Pharmaceutical combination for preventing birth-defect and improving memory
05/30/2012CN101370789B Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
05/30/2012CN101366871B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366870B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366869B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366867B Medicament composition for preventing birth defect and improving memory
05/30/2012CN101366778B Medicament composition for preventing birth defection and improving memory
05/30/2012CN101362679B Antrodia camphoratea pimelie kelone compound for inhibiting B type hepatitis virus
05/30/2012CN101360748B Inhibitors of c-met and uses thereof
05/30/2012CN101352498B Formulation for improving thirst, polyphagia, hypodynamia and polyuria of diabetes patients
05/30/2012CN101346365B Agent for treatment of circulatory failure
05/30/2012CN101337948B 1,5-benzothiazepines compounds, preparation method and application thereof
05/30/2012CN101321527B Method of treating abnormal cell growth
05/30/2012CN101321522B Process for the manufacture of epoxy triazole derivatives
05/30/2012CN101318889B Method of stabilizing reduced coenzyme Q10
05/30/2012CN101317819B Rotigotine flexible liposome and transdermal drug administration formulation for hydrophilic substance
05/30/2012CN101291948B Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
05/30/2012CN101278937B Clear eye lotion containing latanoprost as effective ingredient
05/30/2012CN101274053B Detection method of capsules for curing waist pain
05/30/2012CN101273130B Nucleic acid agents for downregulating H19, and methods of using same
05/30/2012CN101272775B Cosmetic compositions comprising hydroxyfatty acids
05/30/2012CN101267819B Combination of a long-acting hypnotic agent and a short-acting hypnotic agent
05/30/2012CN101264120B Modern Chinese medicine decoction pieces, barrenwort flavonol glycosides decoction pieces and preparation thereof
05/30/2012CN101258144B Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands
05/30/2012CN101254185B Use of cyclic enol ether terpenoid for producing promotive neurocyte proliferate and differentiation medicament
05/30/2012CN101248044B Novel indole compounds
05/30/2012CN101243052B Helix 12 directed non-steroidal antiandrogens
05/30/2012CN101225042B Yacon diterpene acid compounds, medicine composition, preparation method and use in preparation of medicine treating diabetes mellitus
05/30/2012CN101224211B Entecavir solid dispersoid, medicine compounds and preparing method and applications thereof
05/30/2012CN101218203B Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the ss2 adrenergic receptor
05/30/2012CN101190937B Compound with liver-protecting activity
05/30/2012CN101190935B Compound used for viral infect
05/30/2012CN101184726B 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
05/30/2012CN101157731B Preparation method for low agriculture remanet panax ginseng and American ginseng polysaccharide extractive
05/30/2012CN101148667B Preparation and use for affinity human albumin nucleic acid aptamer
05/30/2012CN101148666B Nucleic acid adapter with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof
05/30/2012CN101133074B RNAi modulation of APOB and uses thereof
05/30/2012CN101133072B Hydrogels for the controlled release of bioactive materials
05/30/2012CN101130539B Indole-substituteing imidazoline-2-ketones derivant, preparing method and uses of the same
05/30/2012CN101124195B Purification process
05/30/2012CN101123955B 5HT2C receptor modulator compositions and methods of use
05/30/2012CN101081224B Stable extended release oral dosage composition
05/30/2012CN101073598B Medicinal composition for treating cardiovascular and cerebrovascular disease and its preparation
05/30/2012CN101061105B Potentiators of glutamate receptors
05/30/2012CN101035541B Neuroprotective effect of solubilized UDCA in focal ischemic model
05/30/2012CN101028282B Use of low-molecular weight phaeophytin polyose sulfate in preparation of medicine for treating kidney disease
05/30/2012CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
05/29/2012USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them
05/29/2012US8188313 Analogs of alpha galactosylceramide and uses thereof
05/29/2012US8188312 Acyclic sulfamide derivatives
05/29/2012US8188301 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
05/29/2012US8188291 Heteroaryl-substituted carboxamides and their use as pharmaceuticals
05/29/2012US8188288 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
05/29/2012US8188287 Piperidyl acrylamide antagonists of CCR2
05/29/2012US8188280 3-substituted sulfonyl piperidine derivative
05/29/2012US8188279 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
05/29/2012US8188277 Aromatic compounds for suppressing the generation of collagen
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
1 ... 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 ... 7860